FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...